Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pre-existing immunity against Ad vectors
Hugues Fausther‐Bovendo, Gary Wong
Human Vaccines & Immunotherapeutics (2014) Vol. 10, Iss. 10, pp. 2875-2884
Open Access | Times Cited: 239

Showing 1-25 of 239 citing articles:

SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
Nikolaos C. Kyriakidis, Andrés López‐Cortés, Eduardo Vásconez, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 691
COVID-19 vaccine development and a potential nanomaterial path forward
Matthew D. Shin, Sourabh Shukla, Young Hun Chung, et al.
Nature Nanotechnology (2020) Vol. 15, Iss. 8, pp. 646-655
Open Access | Times Cited: 628
New Vaccine Technologies to Combat Outbreak Situations
Susanne Rauch, Edith Jasny, Kim E. Schmidt, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 553
Coronavirus vaccine development: from SARS and MERS to COVID-19
Yen-Der Li, Wei-Yu Chi, Jun-Han Su, et al.
Journal of Biomedical Science (2020) Vol. 27, Iss. 1
Open Access | Times Cited: 430
Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
Queenie Fernandes, Varghese Inchakalody, Maysaloun Merhi, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 524-540
Open Access | Times Cited: 381
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action
Franz X. Heinz, Karin Stiasny
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 347
Gene Therapy Leaves a Vicious Cycle
Reena Goswami, G. Mani Subramanian, Liliya Silayeva, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 309
Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2
Ian A. McDonald, Sam M. Murray, Catherine J. Reynolds, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 234
Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus
Chean Yeah Yong, Hui Kian Ong, Swee Keong Yeap, et al.
Frontiers in Microbiology (2019) Vol. 10
Open Access | Times Cited: 231
The use of viral vectors in vaccine development
Tatianna Travieso, Jenny Li, Sneha Mahesh, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 183
A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice
Abigail E. Powell, Kaiming Zhang, Mrinmoy Sanyal, et al.
ACS Central Science (2021) Vol. 7, Iss. 1, pp. 183-199
Open Access | Times Cited: 171
A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic
Chris R. Triggle, Devendra Bansal, Hong Ding, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 166
A review of 65 years of human adenovirus seroprevalence
Franck J. D. Mennechet, Océane Paris, Aline Raissa Ouoba, et al.
Expert Review of Vaccines (2019) Vol. 18, Iss. 6, pp. 597-613
Open Access | Times Cited: 153
Polymeric delivery systems for nucleic acid therapeutics: Approaching the clinic
Annette I.S. van den Berg, Chae‐Ok Yun, Raymond M. Schiffelers, et al.
Journal of Controlled Release (2021) Vol. 331, pp. 121-141
Open Access | Times Cited: 143
Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status
Vivek P. Chavda, Rajashri Bezbaruah, Disha Valu, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 432-432
Open Access | Times Cited: 55
Safety and efficacy of COVID‐19 vaccines: A systematic review and meta‐analysis of controlled and randomized clinical trials
Jayesh Beladiya, Anup Kumar, Yogesh Vasava, et al.
Reviews in Medical Virology (2023) Vol. 34, Iss. 1
Closed Access | Times Cited: 43
Vaccination strategies to combat novel corona virus SARS-CoV-2
Satish Chandra Pandey, Veni Pande, Diksha Sati, et al.
Life Sciences (2020) Vol. 256, pp. 117956-117956
Open Access | Times Cited: 120
mRNA as novel technology for passive immunotherapy
Thomas Schlake, Andreas Theß, Moritz Thran, et al.
Cellular and Molecular Life Sciences (2018) Vol. 76, Iss. 2, pp. 301-328
Open Access | Times Cited: 111
Heterologous Immunity: Role in Natural and Vaccine-Induced Resistance to Infections
Babita Agrawal
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 110
Emerging viruses and current strategies for vaccine intervention
Babak Afrough, Stuart Dowall, Roger Hewson
Clinical & Experimental Immunology (2019) Vol. 196, Iss. 2, pp. 157-166
Open Access | Times Cited: 109
Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5–based Constructs
Julio Alonso-Padilla, Tibor Papp, Győző L. Kaján, et al.
Molecular Therapy (2015) Vol. 24, Iss. 1, pp. 6-16
Open Access | Times Cited: 96
Advances in gene-based vaccine platforms to address the COVID-19 pandemic
Deborah Pushparajah, Salma Jimenez, Shirley Wong, et al.
Advanced Drug Delivery Reviews (2021) Vol. 170, pp. 113-141
Open Access | Times Cited: 92
Development of vaccines and antivirals for combating viral pandemics
Norbert Pardi, Drew Weissman
Nature Biomedical Engineering (2020) Vol. 4, Iss. 12, pp. 1128-1133
Open Access | Times Cited: 88
SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?
Saborni Chakraborty, Vamsee Mallajosyula, Cristina M. Tato, et al.
Advanced Drug Delivery Reviews (2021) Vol. 172, pp. 314-338
Open Access | Times Cited: 87
Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2
Xingyue An, Melisa Martinez-Paniagua, Ali Rezvan, et al.
iScience (2021) Vol. 24, Iss. 9, pp. 103037-103037
Open Access | Times Cited: 79
Page 1 - Next Page

Scroll to top